Allogeneic NK Cells: clinical trials recruiting now

Fewer than 3 recruiting trials found.

1

Recruiting trials

10

Conditions studied

13

US states with sites

11

Countries

Phase breakdown

Phase 2 1

Conditions being studied

Condition	Trials
IIM	1
Idiopathic Inflammatory Myopathies (IIMs)	1
Myositis	1
Refractory Rheumatoid Arthritis (RA)	1
Rheumatoid Arthritis (RA	1
Rheumatoid arthritis	1
Scleroderma	1
Sjogren Syndrome	1
Sjogrens Disease	1
Systemic Sclerosis (SSc)	1

Recruiting trials involving Allogeneic NK Cells

AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.
NCT06991114 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 52 locations

Common questions

How many recruiting trials involve Allogeneic NK Cells?

1 recruiting trial across 10 conditions.

Is this list of trials complete?

No. For the full record, search ClinicalTrials.gov.

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.